Literature DB >> 29846855

Microenvironment of Immune Cells Within the Visceral Adipose Tissue Sensu Lato vs. Epicardial Adipose Tissue: What Do We Know?

Martin Klein1, Ivan Varga2.   

Abstract

The chronic low-grade inflammation of the visceral adipose tissue is now fully established as one of the main contributors to metabolic disorders such as insulin resistance, subsequently leading to metabolic syndrome and other associated cardiometabolic pathologies. The orchestration of immune response and the "ratio of responsibility" of different immune cell populations have been studied extensively over the last few years within the visceral adipose tissue in general sense (sensu lato). However, it is essential to clearly distinguish different types of visceral fat distribution. Visceral adipose tissue is not only the classical omental or epididymal depot, but includes also specific type of fat in the close vicinity to the myocardium-the epicardial adipose tissue. Disruption of this type of fat during obesity was found to have a unique and direct influence over the cardiovascular disease development. Therefore, epicardial adipose tissue and other types of visceral adipose tissue depots should be studied separately. The purpose of this review is to explore the present knowledge about the morphology and dynamics of individual populations of immune cells within the visceral adipose tissue sensu lato in comparison to the knowledge regarding the epicardial adipose tissue specifically.

Entities:  

Keywords:  chronic low-grade inflammation; epicardial adipose tissue; immune cells; obesity; visceral adipose tissue

Mesh:

Year:  2018        PMID: 29846855     DOI: 10.1007/s10753-018-0798-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  135 in total

1.  Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat.

Authors:  Harold S Sacks; John N Fain; Ben Holman; Paramjeet Cheema; Aron Chary; Frank Parks; James Karas; Robert Optican; Suleiman W Bahouth; Edward Garrett; Rodney Y Wolf; Russell A Carter; Todd Robbins; David Wolford; Joseph Samaha
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

Review 2.  Detrimental and protective fat: body fat distribution and its relation to metabolic disease.

Authors:  Andrea Booth; Aaron Magnuson; Michelle Foster
Journal:  Horm Mol Biol Clin Investig       Date:  2014-01

3.  Assessment of relationships between novel inflammatory markers and presence and severity of preeclampsia: Epicardial fat thickness, pentraxin-3, and neutrophil-to-lymphocyte ratio.

Authors:  Huseyin Altug Cakmak; Burcu Dincgez Cakmak; Cigdem Abide Yayla; Ebru Inci Coskun; Mehmet Erturk; Ibrahim Keles
Journal:  Hypertens Pregnancy       Date:  2017-06-01       Impact factor: 2.108

Review 4.  A decade of progress in adipose tissue macrophage biology.

Authors:  Andrea A Hill; W Reid Bolus; Alyssa H Hasty
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

5.  Mast cells are not associated with systemic insulin resistance.

Authors:  Elisa Einwallner; Florian W Kiefer; Giuseppe Di Caro; Michael Orthofer; Nadine Witzeneder; Gregor Hörmann; Bianca Itariu; Maximilian Zeyda; Josef M Penninger; Thomas M Stulnig; Harald Esterbauer; Jelena Todoric
Journal:  Eur J Clin Invest       Date:  2016-10-01       Impact factor: 4.686

6.  Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

Authors:  Yifu Qiu; Khoa D Nguyen; Justin I Odegaard; Xiaojin Cui; Xiaoyu Tian; Richard M Locksley; Richard D Palmiter; Ajay Chawla
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

Review 7.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

8.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

9.  Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers.

Authors:  Jeffrey Deiuliis; Zubair Shah; Nilay Shah; Bradley Needleman; Dean Mikami; Vimal Narula; Kyle Perry; Jeffrey Hazey; Thomas Kampfrath; Madhukar Kollengode; Qinghua Sun; Abhay R Satoskar; Carey Lumeng; Susan Moffatt-Bruce; Sanjay Rajagopalan
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

Review 10.  Metainflammation in Diabetic Coronary Artery Disease: Emerging Role of Innate and Adaptive Immune Responses.

Authors:  Vivekanandhan Aravindhan; Haridoss Madhumitha
Journal:  J Diabetes Res       Date:  2016-08-16       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.